# Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease

> **NCT01974817** · PHASE4 · COMPLETED · sponsor: **Michigan State University** · enrollment: 25 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **BIOLOGICAL:** 13-valent conjugate pneumococcal vaccine

## Key facts

- **NCT ID:** NCT01974817
- **Lead sponsor:** Michigan State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-12
- **Final completion:** 2014-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974817, "Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01974817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*